Reproducibility of regional metabolic covariance patterns: Comparison of four populations

Journal of Nuclear Medicine

Volumn 40, Issue 8, 1999, Pages 1264-1269

  Moeller, James R ^b   Nakamura, Toshitaka ^b   Mentis, Marc J ^b   Dhawan, Vijay ^b   Spetsieres, Phoebe ^b   Antonini, Angelo ^b   Missimer, John ^b   Leenders, Klaus L ^b   Eidelberg, David ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

FDG PET; Parkinson's disease; Regional metabolic covariance patterns

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMAGE DISPLAY; IMAGE QUALITY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; TOPOGRAPHY;

BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032868781     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Moeller JR, Strother SC, Sidtis JJ, Rottenberg DA. The scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab. 1987;7:649-658.
2. Moeller JR, Strother SC. A regional covariance approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab. 1991;11:A121-A135.
3. Alexander GE, Moeller JR. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: principal component approach to modeling brain function in disease. Hum Brain Mapping. 1994;2:1-16.
4. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab. 1994;14:783-801.
5. 18F-fluorodopa PET studies. Mov Disord. 1990;5:203-213.
6. Fahn S, Elton RL, and the UPDRS Development Committee. Unified Parkinson disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Floral Park, NJ: Macmillan; 1984:293-304.
7. 18F-fluorodeoxyglucose and PET. J Nucl Med. 1995;36:378-383.
8. Eidelberg D, Moeller JR, Ishikawa T, et al. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol. 1996;39:450-459.
9. Moeller JR, Ishikawa T, Dhawan V, et al. The metabolic topography of normal aging. J Cereb Blood Flow Metab. 1996;16:385-398.
10. Moeller JR, Eidelberg D. Divergent expression of regional metabolic topographies in Parkinson's disease and normal aging. Brain. 1997;120:2197-2206.
11. 18F-fluorodeoxyglucose and PET. Neurology. 1995;45: 1995-2004.
12. Robeson W, Dhawan V, Babchyck B, et al. SuperPETT 3000 time-of-flight tomograph: optimization of factors affecting quantification. IEEE Trans Nucl Sci. 1993;40:135-142.
13. De Grado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med. 1994;35:1398-1406.
14. Eidelberg D, Moeller JR, Kazumata K, et al. Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain. 1997;120:1315-1324.
15. Antonini A, Moeller JR, Nakamura T, et al. The metabolic anatomy of tremor in Parkinson's disease. Neurology. 1998;51:803-810.
16. 2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain. 1996;119:2085-2095.
17. Kearfolt KJ, Carroll LR. Evaluation of the performance characteristics of the PC4600 positron emission tomograph. J Comput Assist Tomogr. 1984;8:502-513.
18. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional neuroimaging: a general linear approach. Hum Brain Mapping. 1995;2:189-210.
19. Ishikawa T, Dhawan V, Chaly T, et al. Clinical significance of striatal dopa decarboxylase activity in Parkinson's disease. J Nucl Med. 1996;37:216-222.
20. 18F]FDOPA/PET. J Nucl Med. 1996;37:1760-1765.
21. Kazumata K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J. Nucl Med. 1998;39:1521-1530.